Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond

dc.contributorFGV
dc.creatorRosina, Mônica Steffen Guise
dc.creatorShaver, Lea
dc.date.accessioned2018-05-10T13:36:11Z
dc.date.accessioned2022-11-03T20:06:52Z
dc.date.available2018-05-10T13:36:11Z
dc.date.available2022-11-03T20:06:52Z
dc.date.created2018-05-10T13:36:11Z
dc.date.issued2012-08
dc.identifier1048-9843 / 1873-3409
dc.identifierhttp://hdl.handle.net/10438/23269
dc.identifier10.1111/j.1748-720X.2012.00658.x
dc.identifier000306312100003
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5031654
dc.description.abstractAccess to medicines faces a new legal threat: border enforcement of drug patents. Using Brazil as an example, this article shows how the right to health depends on international trade. Border seizures of generic drugs present human rights and trade institutions with a unique challenge. Can public health advocates rise to meet it?
dc.languageeng
dc.publisherWiley-Blackwell
dc.relationJournal of law medicine & ethics
dc.rightsrestrictedAccess
dc.sourceWeb of Science
dc.subjectGeneric drugs
dc.titleWhy are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond
dc.typeArticle (Journal/Review)


Este ítem pertenece a la siguiente institución